This segment focuses on the research, development, and manufacturing of anti-infective drugs, including APIs, intermediates, and their preparations. The company employs advanced fermentation technologies and genetic engineering to enhance drug production and efficacy. Research and development efforts are directed towards combating antibiotic resistance and developing novel antimicrobial agents. These drugs address a wide range of bacterial, viral, and fungal infections, improving patient outcomes and reducing the global burden of infectious diseases. The company maintains a strong market position through continuous innovation and strategic partnerships, ensuring a robust pipeline of new anti-infective products. Regulatory compliance and clinical validation are critical aspects of this segment, ensuring the safety and efficacy of the drugs.

This segment is dedicated to the development and production of drugs targeting cardiovascular diseases and immune system disorders. Research and development activities include the discovery of novel therapeutic targets and the development of innovative drug formulations. The company utilizes advanced technologies such as monoclonal antibodies and protein-based therapeutics to create targeted treatments. These drugs aim to improve patient outcomes by managing conditions such as hypertension, heart failure, autoimmune diseases, and inflammatory disorders. The company's market positioning is strengthened by its focus on precision medicine and personalized treatment approaches. Future opportunities include expanding the product pipeline with innovative therapies and establishing collaborations with leading research institutions. Clinical trials and regulatory approvals are essential for bringing these life-saving drugs to market.

This segment focuses on the research, development, and manufacturing of biopharmaceutical products, including biologic medicines, monoclonal antibodies, and protein-based therapeutics. The company leverages cutting-edge biotechnology to develop targeted treatments for complex diseases with high unmet medical needs. Research and development activities include drug discovery, clinical trials, regulatory affairs, and global distribution of pharmaceutical products. The company's market positioning is strengthened by its focus on precision medicine and personalized treatment approaches. Future opportunities include expanding the product pipeline with innovative therapies and establishing collaborations with leading research institutions. Clinical trials and regulatory approvals are essential for bringing these life-saving drugs to market.